Warberg Asset Management »

Ernexa Therapeutics shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Ernexa Therapeutics shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.1k 254k 0.03

More positions owned by Warberg Asset Management

State Str Spdr S&p 500 Etf T Put Put Option
Lumentum Hldgs Note 0.500%12/1 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Microchip Technology Note 1.625% 2/1 (Principal)
Invesco Qqq Tr Put Put Option
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Wisdomtree Note 3.250% 6/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Lci Inds Note 3.000% 3/0 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Cornerstone Strategic Value (CLM)
Txnm Energy Note 5.750% 6/0 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Ernexa Therapeutics

Armistice Capital
Warberg Asset Management
Clear Street Group

View all funds holding Ernexa Therapeutics